Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Join | Sign in

  News Archive

BioClinica Opens Research Triangle Park Office
Friday, March 27, 2015
Sponsors and CRO strategic partners drive RTP expansion.

AbbVie and C2N Enter into a Worldwide License Agreement
Friday, March 27, 2015
License agreement to develop and commercialize a portfolio of anti-tau antibodies for the treatment of Alzheimer's Disease.

Ebola Test Vaccines Appear Safe in Phase 2 Liberian Clinical Trial
Friday, March 27, 2015
Liberia-U.S. partnership planning Phase 3 trial and study of Ebola survivors.

MorphoSys and Celgene Mutually Agree to End MOR202 Collaboration
Friday, March 27, 2015
MorphoSys regains rights to MOR202 antibody against CD38 and updates its financial guidance for 2015.

Recipharm and Adroit Science Form Collaboration
Thursday, March 26, 2015
Company will support Recipharm’s pharmaceutical development with high quality solid state characterization services.

AFC Achieves Success in Operation of 101 Cell Stack Trial
Wednesday, March 25, 2015
Delivery of 240kW KORE fuel cell system scheduled for the second half of 2015.

Biogen Idec Presents Positive Interim Results from Phase 1b Study
Saturday, March 21, 2015
Aducanumab (BIIB037) reduced brain amyloid plaque levels and slowed cognitive decline in patients with prodromal or mild Alzheimer’s disease in Phase 1b study.

Dr. Falk Pharma and Zedira Enter Phase I Clinical Trials for ZED1227
Saturday, March 21, 2015
A direct acting inhibitor of tissue transglutaminase.

Xcelience to Expand Headquarter Operations in Tampa
Friday, March 20, 2015
International pharmaceutical development and manufacturing company will create 100 new jobs, capital investment of more than $9 million.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 3495

SELECTBIO Market Reports
Go to LabTube
Go to eposters